Embrace city science as a vital partner in architecture, merging creativity with data to build resilient and equitable urban ...

For the quarter ended June 30, 2025, Calamos Growth And Income Fund returned 11.91% (Class I shares at NAV) versus the S&P ...

Let’s dig into the relative performance of Evolent Health (NYSE:EVH) and its peers as we unravel the now-completed Q2 ...